The burden of cancer in metabolic dysfunction-associated steatotic liver disease

Romanian Journal of Morphology and Embryology, Год журнала: 2025, Номер 65(4), С. 627 - 635

Опубликована: Фев. 13, 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic worldwide and has become a major public health problem. MASLD frequently progresses to cirrhosis hepatocellular carcinoma, but recent studies also show frequent association with extrahepatic cancers. One of mechanisms involved in both locations insulin resistance hyperinsulinemia. The aim this narrative review was present main etiopathogenic cancer development patients MASLD.

Язык: Английский

---

Reply - Letter to the Editor – “The genetically predicted causal associations between circulating 3-hydroxybutyrate levels and malignant neoplasms: A pan-cancer Mendelian randomization study”

Clinical Nutrition, Год журнала: 2024, Номер 44, С. 129 - 131

Опубликована: Ноя. 13, 2024

Язык: Английский

---

Letter to the Editor - The genetically predicted causal associations between circulating 3-hydroxybutyrate levels and malignant neoplasms: A pan-cancer Mendelian randomization study

Clinical Nutrition, Год журнала: 2024, Номер 44, С. 122 - 123

Опубликована: Дек. 6, 2024

Язык: Английский

---